Farms.com Home   News

Questions You Should Be Asking Yourself First, Before Seeking Advice On Choosing The Right Bull

Kansas State Beef Cattle Specialist Dr. Bob Weaber gets a lot of questions from cattle producers about what kind of bulls they ought to be buying. Farm Director Ron Hays talks with Weaber about how he responds when he is approached for this kind of advice. He says he usually turns the table on the producer and begins asking his own questions.



“I usually put three questions to them,” Weaber said, “Depending on what your response is there, it has an influence on what direction of genetics you might go.”

The three questions Dr. Weaber typically puts to producers are 1.) how do you sell calves, what is your marketing endpoint; 2.) how do you generate replacement heifers, raise your own or buy them; and 3.) where are you at today with the cattle you run on your operation, what genetics make up your herd currently - are they mostly British, continental, bos indicus or some combination of those?

“Whatever the case is,” Weaber said, “trying to figure out a little bit in terms of breed complementarity, what direction we might head as we think about combining optimality in terms of maternal and growth and carcass traits to produce really what I like to call environmentally adapted cows.”

Click here to see more...

Trending Video

New discovery may lead to better vaccines for pork producers

Video: New discovery may lead to better vaccines for pork producers



Porcine reproductive and respiratory syndrome virus (PRRSV) causes severe disease in pigs, leading to significant economic losses for pork producers across the globe. It’s estimated that PRRS costs the Canadian pork industry $130M annually. Using the CMCF beamline, researchers from the University of Manitoba and the Leiden University Medical Centre (Netherlands) were able to see the structure of the PRRSV protease, a type of protein the pathogen uses to suppress a host’s immune system. The vital information they uncovered can be used to develop new vaccines against PRRSV and also helps inform development of vaccines against emerging human viruses.